School Of Medicine At Mount Sinai Icahn serves as Executive at Sema4 Holdings Corp., where they oversee executive responsibilities. Since joining the company, School Of Medicine At Mount Sinai Icahn has executed 2 insider transactions totaling $25.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 24, 2024 involved transacting 9,360,374 shares valued at $2.3M.
School Of Medicine At Mount Sinai Icahn currently holds 19,317,248 shares of Sema4 Holdings Corp. (SMFR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, School Of Medicine At Mount Sinai Icahn has been a net buyer of SMFR stock. They have purchased $25.0M and sold $0 worth of shares.
School Of Medicine At Mount Sinai Icahn's most recent insider trade was on Apr 24, 2024, when they sold 9,360,374 shares at $0.25 per share.
Get notified when new Form 4 filings are submitted
| $4.00 |
| Discretionary |